Introduction
The aetiology of primary biliary cirrhosis (PBC) remains unknown and while many immunological abnormalities have been observed, conventional immunosuppressive agents have not proved to be helpful (Carman and Gianseracusa, 1955; Howat et al., 1966; Heathcote, Ross and Sherlock, 1976) . The earliest lesion in PBC is infiltration of the intrahepatic biliary tree by mononuclear cells and granulomata (Rubin, Schaffner and Popper, 1965; Scheuer, 1967) , suggesting cellular rather than humoral immunity might be of pathogenetic significance. Furthermore, since delayed hypersensitivity skin responses to common antigens and lymphocyte transformation to phytohaemagglutinin (PHA) are reported as defective in at least 50% of patients with PBC (Fox, Scheuer and Sherlock, 1973; Macsween et al, 1973) , it is possible that the disease is due to impaired cellmediated immunity and might respond to the immunostimulant levamisole. Only 3 of the 7 patients had raised lgM levels and there was no consistent change after levamisole. Antimitochondrial antibody was present in a titre of more than 1:400 in all patients and remained so throughout the study. Immune complexes were elevated in 6 of the 7 and during the trial became normal in only one case (of the 4 assessed). Lymphocyte transformation to PHA was normal in all patients before treatment. However, they were anergic in their response to skin testing with common antigens and no patient could be sensitized to DNCB (Table 3) .
No patients experienced any significant side effect that could be attributed to levamisole, and in particular there were no blood dyscrasias. Indeed, 3 patients who entered the trial with platelet counts persistently less than 100 x 109/litre achieved normal counts within one week of starting therapy. The significance of this observation is uncertain.
Discussion
The aetiology of PBC remains uncertain and while the condition may be immunologically mediated it does not respond favourably to conventional immunosuppressive measures (Carman and Gianseracusa, 1955; Howat et al., 1969; Heathcote et al., 1976) .
Although there are consistent alterations in humoral immunity (high plasma IgM levels (Feizi, 1968) 
